ISIN | LU2404423373 |
---|---|
Valor Number | 115550442 |
Bloomberg Global ID | WEHUDAD LX |
Fund Name | Wellington Management Funds (Luxembourg) III SICAV - Wellington Emerging Markets Health Care Equity Fund USD UD AccU |
Fund Provider |
Wellington Management Company LLP
Web: https://www.wellingtonfunds.com |
Fund Provider | Wellington Management Company LLP |
Representative in Switzerland |
BNP Paribas, Paris, Zurich Branch Zürich |
Distributor(s) |
Wellington Global Administrator Ltd. Hamilton |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to seek long-term total returns in excess of the S&P BMI Emerging Markets Health Care Index (the "Index"), primarily investing in health care companies that are located in and/or conduct substantial business in emerging market countries, inclusive of frontier market countries (as defined by MSCI). |
Peculiarities |
Current Price * | 7.86 USD | 04.11.2024 |
---|---|---|
Previous Price * | 7.74 USD | 01.11.2024 |
52 Week High * | 8.27 USD | 04.10.2024 |
52 Week Low * | 6.65 USD | 18.04.2024 |
NAV * | 7.86 USD | 04.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 879,117 | |
Unit/Share Assets *** | 7,787 | |
Trading Information SIX |
YTD Performance | +0.58% |
29.12.2023 - 04.11.2024
29.12.2023 04.11.2024 |
---|---|---|
YTD Performance (in CHF) | +3.71% |
29.12.2023 - 04.11.2024
29.12.2023 04.11.2024 |
1 month | -5.00% |
04.10.2024 - 04.11.2024
04.10.2024 04.11.2024 |
3 months | +11.62% |
05.08.2024 - 04.11.2024
05.08.2024 04.11.2024 |
6 months | +8.56% |
06.05.2024 - 04.11.2024
06.05.2024 04.11.2024 |
1 year | +0.87% |
06.11.2023 - 04.11.2024
06.11.2023 04.11.2024 |
2 years | -2.60% |
04.11.2022 - 04.11.2024
04.11.2022 04.11.2024 |
3 years | -21.42% |
16.12.2021 - 04.11.2024
16.12.2021 04.11.2024 |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Apollo Hospitals Enterprise Ltd | 6.26% | |
---|---|---|
Innovent Biologics Inc | 4.96% | |
IHH Healthcare Bhd | 4.44% | |
Torrent Pharmaceuticals Ltd | 4.40% | |
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A | 4.21% | |
Cipla Ltd | 3.97% | |
Hapvida Participacoes Investimento SA Ordinary Shares | 3.59% | |
Fortis Healthcare Ltd | 3.58% | |
Genomma Lab Internacional SAB de CV Class B | 3.42% | |
Sino Biopharmaceutical Ltd | 3.25% | |
Last data update | 30.09.2024 |
TER | 1.85% |
---|---|
TER date | 15.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.10% |
Ongoing Charges *** | 1.85% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |